The recall covers all lots of Excedrin Extra Strength Caplets and Excedrin Tension Headache Caplets with expiration dates of Dec. 20, 2014 or earlier.
The recall was initiated after the U.S. Food and Drug Administration received reports of chipped and broken pills.
As well, it had reports of inconsistent bottle packaging clearance practices, which could result in the bottles containing foreign tablets, caplets, or capsules.
The FDA informed consumers that mixing of different products in the same bottle could result in consumers taking a higher or lower dose than intended or receiving an unintended ingredient.
The products are marketed by Novartis Consumer Health Canada Inc., which is voluntarily recalling the drugs.
For information concerning the recall or how to return the drugs, consumers should directly contact Novartis Consumer Health Canada Inc.’s consumer relationship centre at 1-888-788-8181.Suggest a correction